2023 Q3 Form 10-Q Financial Statement

#000114036123039724 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $487.0K $469.0K
YoY Change 17.83% -1.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $610.3K
YoY Change 15.16%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.470K
YoY Change -9.52%
% of Gross Profit
Operating Expenses $719.0K $849.0K
YoY Change 19.37% 2.71%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$232.0K -$380.0K
YoY Change 22.74% 8.16%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$232.0K -$380.0K
YoY Change 22.74% 8.16%
Net Earnings / Revenue -47.63% -81.03%
Basic Earnings Per Share -$0.39 -$0.63
Diluted Earnings Per Share -$0.39 -$0.63
COMMON SHARES
Basic Shares Outstanding 600.1K 600.1K
Diluted Shares Outstanding 600.1K 600.1K

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.520M
YoY Change -39.21%
Cash & Equivalents $1.290M $1.520M
Short-Term Investments
Other Short-Term Assets $350.0K
YoY Change 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.382M
YoY Change -28.55%
LONG-TERM ASSETS
Property, Plant & Equipment $5.189K $6.729K
YoY Change -64.21% -60.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.6K
YoY Change -27.8%
Total Long-Term Assets $135.3K
YoY Change -30.72%
TOTAL ASSETS
Total Short-Term Assets $2.382M
Total Long-Term Assets $135.3K
Total Assets $1.965M $2.517M
YoY Change -43.6% -28.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.068M
YoY Change 13.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.087M
YoY Change 10.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.087M
Total Long-Term Liabilities $0.00
Total Liabilities $766.2K $1.087M
YoY Change -42.62% -8.77%
SHAREHOLDERS EQUITY
Retained Earnings -$52.69M -$52.46M
YoY Change 1.84% 1.76%
Common Stock $6.001K $6.001K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.199M $1.431M
YoY Change
Total Liabilities & Shareholders Equity $1.965M $2.517M
YoY Change -43.6% -28.67%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$232.0K -$380.0K
YoY Change 22.74% 8.16%
Depreciation, Depletion And Amortization $2.470K
YoY Change -9.52%
Cash From Operating Activities -$830.9K
YoY Change 95.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -830.9K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -830.9K
YoY Change 95.83%
FREE CASH FLOW
Cash From Operating Activities -$830.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001162283
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2087054
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276437
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1810617
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-380003
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1430614
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3036245
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-347113
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2689132
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-351332
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2337800
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-380003
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-380003
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-351332
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-351332
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-656440
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-656440
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-698445
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-698445
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.16
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000

Files In Submission

Name View Source Status
mghl-20230630_cal.xml Edgar Link unprocessable
mghl-20230630_lab.xml Edgar Link unprocessable
mghl-20230630_def.xml Edgar Link unprocessable
0001140361-23-039724-index-headers.html Edgar Link pending
0001140361-23-039724-index.html Edgar Link pending
0001140361-23-039724.txt Edgar Link pending
0001140361-23-039724-xbrl.zip Edgar Link pending
brhc20057436_10q.htm Edgar Link pending
brhc20057436_ex31-1.htm Edgar Link pending
brhc20057436_ex31-2.htm Edgar Link pending
brhc20057436_ex32-1.htm Edgar Link pending
brhc20057436_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mghl-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
mghl-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brhc20057436_10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending